David Kallenberg
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Clusterin in disease pathology
Papers in
- Oncology 5
- Clusterin in disease pathology 3
- Cancer Cells and Metastasis 1
-
- RNA regulation and disease 2
- S100 Proteins and Annexins 1
- Co-authors
- Dorothy C. Bennett (3 shared papers)Eran Eyal (1 shared paper)Menashe Bar‐Eli (1 shared paper)Ninette Amariglio (1 shared paper)Jasmine Jacob‐Hirsch (1 shared paper)Lyn M. Duncan (1 shared paper)Gal Markel (1 shared paper)Yael Nemlich (1 shared paper)
- Journals
- Cancer Research (1 paper)Med (1 paper)RSC Chemical Biology (1 paper)Pigment Cell & Melanoma Research (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United KingdomUnited StatesMexico
In The Last Decade
David Kallenberg
5 papers receiving 297 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 64
- Oncology 78
- Molecular Biology 210
- Cell Biology 35
- Immunology 43
Countries citing papers authored by David Kallenberg
This map shows the geographic impact of David Kallenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kallenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kallenberg more than expected).
Fields of papers citing papers by David Kallenberg
This network shows the impact of papers produced by David Kallenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kallenberg. The network helps show where David Kallenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside David Kallenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 141 | |
| 2 | 2010 | 64 | |
| 3 | 2021 | 45 | |
| 4 | 2021 | 27 | |
| 5 | 2011 | 24 | |
| 6 | 2024 | 0 | |
| 7 | 2018 | 0 |
About David Kallenberg
David Kallenberg is a scholar working on Oncology, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 7 papers that have together received 301 indexed citations. Recurring topics across this work include Clusterin in disease pathology (3 papers), RNA regulation and disease (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Ferroptosis and cancer prognosis (1 paper), Cancer Cells and Metastasis (1 paper), S100 Proteins and Annexins (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Cancer Research (64 citations), Oncology (78 citations), Molecular Biology (210 citations), Cell Biology (35 citations) and Immunology (43 citations). David Kallenberg has collaborated with scholars based in United Kingdom, United States and Mexico. Frequent co-authors include Dorothy C. Bennett, Eran Eyal, Menashe Bar‐Eli, Ninette Amariglio, Jasmine Jacob‐Hirsch, Lyn M. Duncan, Gal Markel, Yael Nemlich, Víctor G. Prieto and Elad Jacoby. Their work appears in journals such as Cancer Research, Med, RSC Chemical Biology, Pigment Cell & Melanoma Research and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.